A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries
Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, received a six million krona Indo – Swedish grant for the project, ‘Improved, affordable single strain whole cell-B subunit oral cholera vaccine’.